Publications


Notice: Undefined variable: output in /var/www/html/alo/wp-content/themes/alo-mit-fpd-3/taxonomy-topic.php on line 17

Notice: Undefined variable: filter in /var/www/html/alo/wp-content/themes/alo-mit-fpd-3/taxonomy-topic.php on line 17

Health Care Loans For Hep C Cure

2016
Lo, Andrew W., and David Weinstock (2016), ‘Health Care Loans’ for Hep C Cure, Boston Globe, February 24.

Buying Cures Versus Renting Health: Financing Health Care with Consumer Loans

2016
Montazerhodjat, Vahid, David M. Weinstock, and Andrew W. Lo (2016), Buying Cures versus Renting Health: Financing Health Care with Consumer Loans, Science Translational Medicine 8 (327), 327ps6.

Financing Drug Discovery via Dynamic Leverage

2016
Montazerhodjat, Vahid, John J. Frishkopf, and Andrew W. Lo (2016), Financing Drug Discovery via Dynamic Leverage, Drug Discovery Today 21 (3), 410–414.

Lessons From Hollywood: A New Approach To Funding R&D

2016
Lo, Andrew W., and Gary Pisano (2016), Lessons From Hollywood: A New Approach to Funding R&D, Sloan Management Review 57 (2), 47–57.

Megafunding Drug Research

2015
Jung, Edward, and Andrew W. Lo (2015), Megafunding Drug Research, Project Syndicate, December 9.

FAQs for Megafund Financing

2015
Fernandez, Jose-Maria, Roger M. Stein, and Andrew W. Lo (2015), FAQs for Megafund Financing.

Funding Translational Medicine via Public Markets: The Business Development Company

2015
Forman, Sandra M., Andrew W. Lo, Monica Shilling, and Grace K. Sweeney (2015), Funding Translational Medicine via Public Markets: The Business Development Company, Journal of Investment Management 13 (4), 9–32.

Financing Translation: Analysis of the NCATS Rare-Diseases Portfolio

2015
Fagnan, David E., N. Nora Yang, John C. McKew, and Andrew W. Lo (2015), Financing Translation: Analysis of the NCATS Rare-Diseases Portfolio, Science Translational Medicine 7 (276), 276ps3.

To Cure Cancer, Provide a Profit Motive

2014
Lo, Andrew W., and Roger M. Stein (2014), To Cure Cancer, A Profit Motive, Scientific American SA Forum, March 26.

Financing Drug Discovery for Orphan Diseases

2014
Fagnan, David E., Austin A. Gromatzky, Roger M. Stein, Jose-Maria Fernandez, and Andrew W. Lo (2014), Financing Drug Discovery for Orphan Diseases, Drug Discovery Today 19 (5), 533–538.

Wall Street’s Next Bet: Cures for Rare Diseases

2014
Lo, Andrew W. (2014), Wall Street’s Next Bet: Cures for Rare Diseases, Fortune, January 21.

New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc.

2014
Lo, Andrew W., and Sourya V. Naraharisetti (2014), New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc., Journal of Investment Management 12 (1), 4–19.

Financial Orphan Therapies Looking for Adoption

2014
Sukhatme, Vikas, Kathy Fang, Andrew W. Lo, and Vidula Sukhatme (2014), Financial Orphan Therapies Looking for Adoption, Health Affairs Blog, March 6.

Unintended Consequences of Expensive Cancer Therapeutics The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

2014
Fojo, Tito, Sham Mailankody, and Andrew W. Lo (2014), Unintended Consequences of Expensive Cancer Therapeutics - The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity: The John Conley Lecture, JAMA Otolaryngology - Head and Neck Surgery 140 (12), 1225–1236.

Parallel Discovery of Alzheimers Therapeutics

2014
Lo, Andrew W., Carole Ho, Jayna Cummings, and Kenneth S. Kosik (2014), Parallel Discovery of Alzheimer’s Therapeutics, Science Translational Medicine 6 (241), 241cm5.